Hyaluxelle®
Medical device
Hyaluxelle® is indicated for adult women to treat the vulvar vestibule in cases of atrophy, dryness, burning or non-infectious itching, or pain of the vaginal introitus during intercourse8.

Highlights
Protocol
Two treatment sessions with an interval of 30 days, following the suggested injection technique8
Improvement
Improvement in vaginal symptoms and sexual function in patients with VVA4,6,7
Tolerability
Well tolerated in the genital area4
Quality of life
Positive trend on HRQoL4
Technology
Nahyco®Hybrid technology: stabilized high and low molecular weights HA for a synergistic contribution to tissue regeneration1
Clinical evidence
Improvement in vaginal symptoms of VVA4
Supports the restoration of vaginal tissue structure6
Improvement in sexual function4,7
Acceptable safety profile4,6
Beneficial impact on frequency of sexual intercourse, emotions and relationships4,7
Hyaluxelle® product line

References
- 1 / Humzah D, et al. Int J Mol Sci. 2024;25(6):3216.
- 2 / Christmas M, et al. Clin Obstet Gynecol. 2024;67(1):101-14.
- 3 / Benini V, et al. Medicina (Kaunas). 2022;58(6):770.
- 4 / Garavaglia E, et al. Med Devices (Auckl). 2020;13:399-410.
- 5 / Nasreen SZA, et al. American Journal of Internal Medicine. 2019;7(6):154-62.
- 6 / Garavaglia E, et al. Aesthetic Medicine. 2023;9(1):35-42.
- 7 / Mohammed GF, et al. Health Sci Rep. 2023;6(3):e870.
- 8 / HYALUXELLE®. Instructions for Use.
- 9 / Meston CM, et al. J Sex Med. 2020;17(1):17-25.


